Simplex Trading’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.6K Sell
11,000
-53,300
-83% -$216K ﹤0.01% 5977
2025
Q4
$415K Sell
64,300
-7,000
-10% -$43.6K ﹤0.01% 3491
2025
Q3
$398K Buy
71,300
+59,000
+480% +$255K ﹤0.01% 4115
2025
Q2
$40K Buy
12,300
+6,700
+120% +$19.2K ﹤0.01% 6133
2025
Q1
$16K Buy
5,600
+1,300
+30% +$3.94K ﹤0.01% 6740
2024
Q4
$15K Sell
4,300
-9,200
-68% -$42.4K ﹤0.01% 6883
2024
Q3
$67K Sell
13,500
-2,300
-15% -$8.95K ﹤0.01% 5610
2024
Q2
$41K Buy
15,800
+6,500
+70% +$21.7K ﹤0.01% 6265
2024
Q1
$39K Buy
+9,300
New +$31K ﹤0.01% 6487
2022
Q3
Sell
-10,300
Closed -$6K 9840
2022
Q2
$6K Buy
10,300
+3,000
+41% +$3.99K ﹤0.01% 8689
2022
Q1
$19K Sell
7,300
-10,000
-58% -$29.2K ﹤0.01% 8285
2021
Q4
$67K Buy
17,300
+13,800
+394% +$69.3K ﹤0.01% 6821
2021
Q3
$13K Hold
3,500
﹤0.01% 8749
2021
Q2
$13K Buy
3,500
+3,343
+2,129% +$13.4K ﹤0.01% 8906
2021
Q1
$81K Buy
157
+137
+685% +$729 ﹤0.01% 6027
2020
Q4
$10K Sell
20
-46
-70% -$276 ﹤0.01% 7387
2020
Q3
$32K Buy
66
+50
+313% +$327 ﹤0.01% 6003
2020
Q2
$7K Buy
16
+6
+60% +$28 ﹤0.01% 6804
2020
Q1
$2K Buy
+10
New +$38 ﹤0.01% 7151

Other funds holding AQST

Simplex Trading's AQST Position: Q4 2025 in Review

Simplex Trading sold out of Aquestive Therapeutics (AQST) in Q4 2025, closing a stake of 51,177 shares — an estimated $319K sold.

Simplex Trading first reported a position in AQST in Q1 2020 and held it in 13 quarters. The position peaked at $343K in Q4 2021. 176 funds tracked by Wall St. Rank hold AQST as of Q4 2025.

  • Simplex Trading reported no remaining Aquestive Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 51,177 Aquestive Therapeutics shares in Q4 2025, an estimated $319K.
  • Simplex Trading first reported a position in Aquestive Therapeutics in Q1 2020 and held it in 13 quarters.
  • Simplex Trading's Aquestive Therapeutics position peaked at $343K in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.